43 results
diagnosis rheumatology differential algorithm dermatology disease idsa cancer chronic hepatology hivaids opportunistic prevention renal table barre cll guillain hemophagocytic hlh
IDSA Aspergillosis Treatment • Invasive pulmonary aspergillosis (IPA) • CNS aspergillosis • Cardiac Aspergillus infection •
Aspergillosis Treatment ... • Invasive pulmonary ... of eye Infectious ... Aspergillosis #Treatment ... #management #pharmacology
Here is a quick guide on the common direct-acting antivirals (DAAs) for chronic hepatitis C virus
chronic hepatitis C virus ... (HCV) infection ... Antivirals #table #treatment ... HepC #HepatitisC #Management ... #Pharmacology
Approach to the Rash in a an oncology patient - MINT-C Mnemonic M - Malignancy: Leukemia cutis,
the Rash in a an oncology ... Dermatoses: Sweet Syndrome ... Gangrenosum, NEH T - Treatment ... #skin #Rash #oncology ... MINTC #Mnemonic #dermatology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Myelodysplastic Syndrome ... risk-stratification • Risks: infection ... only curative treatment ... #treatment #hematology ... #oncology
Adjuvant therapies in critical care: steroids to treat infectious diseases - Severe Community Acquired Pneumonia
steroids to treat infectious ... respiratory distress syndrome ... InfectiousDiseases #Infections ... #Pharmacology # ... Management #Treatment
Causes of Fatigue - Differential Diagnosis Algorithm Endocrine • Hypo/Hyperthyroidism • Diabetes • Pituitary Insufficiency • Adrenal
Neoplastic / Hematologic ... • Malignancy Infectious ... Chronic Obstructive Pulmonary ... Myasthenia Gravis Pharmacologic ... Chronic Fatigue Syndrome
Aplastic Anemia - Overview Who? • M = F • 3 peaks: 1) Childhood 2) 15-25 years 3) >60 years What? • Aplastic anemia
Idiopathic • Infections ... aplastic anemia Treatment ... Aplastic #Anemia #oncology ... #hematology #diagnosis ... #management
Differentiation Syndrome in APML Epidemiology: • Incidence: common in APL (2-48% depending on the study) • Triggers:
Differentiation Syndrome ... Imaging: CXR- pulmonary ... Differential Diagnosis: Infection ... APML #diagnosis #management ... #hematology #oncology
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis. Currently, edoxaban and rivaroxaban are the only
algorithm for the treatment ... thrombosis; PE = pulmonary ... Anticoagulation #Management ... #Hematology #Oncology
►
 Hemophagocytic Lymphohistiocytosis (HLH) Pathophysiology: Triggering factor (infection,...)→Activation of CD8 T cells (IFN-y) → Excessive activation of macrophages
+++: Virus (EBV, ... Unknown cause Treatment ... Lymphohistiocytosis #diagnosis #management ... #treatment #summary ... #rheumatology
No results found for "Varus management pharmacology treatment pulmonary infections syndrome hematology oncology"
Try removing search terms or sorting by relevance
Or Upload an image for you and others searching for #Varus #management #pharmacology #treatment #pulmonary #infections #syndrome #hematology #oncology